Resistance of Plasmodium falciparum to antimalarial drugs: Impact on malaria pre-elimination in Madagascar;Résistance de Plasmodium falciparum aux antipaludiques : Impact sur la pré-élimination du paludisme à Madagascar

Medecine Tropicale

Volumn 71, Issue 3, 2011, Pages 298-304

  Andriantsoanirina, V ^a   Menard D ^a   Tuseo L ^b   Ratsimbasoa, A ^c   Durand, R ^d  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF ANTANANARIVO   (Madagascar)

^d AVICENNE HOSPITAL   (France)

Author keywords

Antimalarial drug resistance; Madagascar; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; CHLOROQUINE; PYRIMETHAMINE PLUS SULFADOXINE; DIHYDROFOLATE REDUCTASE;

AFRICA; ALLELE; ANTIMALARIAL DRUG RESISTANCE; DRUG EFFICACY; DRUG TREATMENT FAILURE; FOLLOW UP; HAPLOTYPE; HUMAN; IN VITRO STUDY; MADAGASCAR; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; PREGNANCY DISORDER; PREVALENCE; REVIEW; DRUG RESISTANCE; GENETICS; MUTATION;

ANTIMALARIALS; DRUG RESISTANCE; HAPLOTYPES; HUMANS; MADAGASCAR; MALARIA, FALCIPARUM; MUTATION; PLASMODIUM FALCIPARUM; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 80155210287     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. WHO. World health Organization. Madagascar Database. National Level Report. 2010.
2. Bamadas C, Ratsimbasoa A, Ranaivosoa H, Ralaizandry D, Raveloariseheno D, Rabekotonorina V et al. Short report; prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar. Am J Trop Med Hyg 2007 ; 77 : 1039-42.
3. Bamadas C, Ratsimbasoa A, Tichit M, Bouchier C, Jaheviira M, Picol S, et al. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdrl and pvcrt-o genes. Amimicrob Agenis Chemother 2008 ; 52 : 4233-40.
4. Mouchet J, Laventure S, Blanchy S, Fioramonti R, Rakotonjanabelo A, Rabarison P, et al. La reconquête des Hautes terres de Madaga,scar par le paludisme. Bull Soc Pathol Exol 1997; 90: 162-8.
5. Mouchet J, Carnevale P Coosemans M, Julvez J, Manguin S, Richard-Lenoble D, Sircoulon J. Biodiversité du paludisme dans le monde. Libbey J ed. Paris 2004 ; 428 p.
6. Romi R. Razaiarimanga MC, Raharimanga R. Rakotondraibe EM, Ranaivo LH, Pietra V, el al Impaci of the malaria control campaign (1993-1998) in the highlands of Madagascar: parasilological and enlomological data. Am J Trop Med Hyg 2002 ; 66 : 2-6.
7. Ministère de la Santé et du Planning Familial. Politique National de Lutte contre le Paludisme. 2005 ; 44 p.
8. Worid Health Organization. WHO Global Malaria Program. Feb 2009.
9. Willcox ML, Rakolondrazafy E. Andriamanalimanana R, Andrianasolo D, Rasoanaivo P. Decreasing clinical efficacy of chloroquine in Ankazobe, Central Highlands of Madagascar /ran.v H Soc Trop Med Hyg 20(M ; 98 : 311-4.
10. Randrianarivelojosia M, Raharimalala L, Randriamanantena A, Jambou R. Chimiorésistance de Plasmodium falciparum sur les régions colières malgaches Med Trop 2000; 60: 243-9.
11. Andrianlsoanirina V. Ménard D, Tuseo L, Durand R. History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar Scand J Infect D/i2010; 42: 22-32.
12. Andrianlsoanirina V, Ratsimbasoa A, Bouchier C, Jahevitra M, Rabearimanana S, Radrianjafy R, el al. Plasmodium falciparum drug resistance in Madagascar: lacing the spread of unusual Pfdhfr and pltndr-1 haplolypes and Ihe decrease of dihy-droartemisinin susceptibility. Antimicrob Agents Chemother 2009 ; 53 :4588-97.
13. Ménard D. Ratsimbasoa A, Randrianarivelojosia M, Rabarijaona LP Raharimalala L, Domarle O, et al. Assessmeni of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials. Malar J 2008 ; 7 : 55.
14. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resislaiiic and nealmenl outcome in falciparum malaria. Malar 7 2009:8:89.
15. Rason MA, Andriananlenaina HB, Ariey F, Raveloson A, Domarle O, Randrianarivelojosia M. Prevalent Pfmdrl N86Y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains. Am J Trop Med Hyg 2007 ; 76 : 1079-83.
16. Andriantsoanirina V. Ratsimbasoa A, Bouchier C, Tichit M, Jahevitra M. Rabearimanana S, el al. Chloroquine clinical failures in P. falciparum malaria are associated with mutant Plmdr-1, noi Pfcri in Madagascar PLoS One 2010; 5 : el3281.
17. Sá JM. Two O, Hayton K, Reyes S. Fay MP Ringwald P, el al. Geographic patterns oí Plasmodium falciparum drug resistance distinguished by differenlial responses to amodiaquine and chloroquine. Proc Natl Acad Sci U S A 2009 ; 106 : 18883-9.
18. Ariey F, Fandeur T, Durand R, Randrianarivelojosia M, Jambou R. Legrand E, et al. Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J 2006; 5:34.
19. Wootton JC, Feng X, Ferdig MT. Cooper RA, Mu J. Baruch Dl, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002 ; 418 : 320-3.
20. Randrianarivelojosia M, Harisoa JL, Rabarijaona LP, Raharimalala LA. Ranaivo L, Pietra V, el al. in vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar. Parassitologia 2002 ; 44 : 141-7.
21. Price RN. Uhlemann AC, Brockman A, McGready R. Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased Pfmdr1 gene copy number Lancet 2004: 364 : 438-47.
22. Sidhu AB. Uhlemann AC. Valderramos SG, Valderramos JC, Krishna S, Fidock DA. Decreasing Pfmdrl copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J Infect Dis 2006; 194 : 528-35.
23. Ferdig MT, Cooper RA, Mu J, Deng B, Joy DA, Su XZ, et al Dissecting the loci of low-level quinine resi.stance in malaria parasites. Mol Microbiol 2004 ; 52 : 985-97.
24. Henry M, Briolant S, Zettor A, Pelleau S, Baragatti M, Barel E. et al. Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob Agents Chemother 2009 ; 53 : 1926-30.
25. Vinayak S, Alam MT, Upadhyay M, Das MK, Dev V, Singh N, et al. Extensive genetic diversity in the Plasmodium falciparum Na+/H+ exchanger 1 transporter protein implicated in quinine resistance. Amimicrob Agems Chemother 2007 ; 51 : 4508-11.
26. Choudhary V, Sharma YD. Extensive heterozygosity in flanking microsatellites of Plasmodium falciparum Na-f/H+ exchanger (/j/ñ/ic-/) gene among Indian isolates. é2009; 109 : 241-4.
27. Andriantsoanirina V. Ménard D. Rabearimanana S, Huben V. Bouchier C. Tichit M. el al. Association of microsalellite variations of Pla.mtodium falciparum Na+/H+ exchanger (Pfnhe-l) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Much. Am J Trop Med Hyg 2010; 82 : 782-7.
28. Nkrumah LJ, Riegelhaupt PM, Moura P, Johnson DJ, Patel J, Hayton K, et al. Probing the multifactorial basis oí Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger Pfnhe. Mol BiochemParasitonm): 165: 122-31.
29. Randrianarivelojosia M, Ariey F. Raharimalala LA, Parzy D, Rogier C, Jambou R. Current absence of pyrimethamine resistance of Plasmodium falciparum in Madagascar Trans R Soc Trop Med Hyg 2002 ; 96 : 557-9.
30. Ménard D, Andriantsoanirina V, Jahevitra M, Bamadas C, Tichit M, Bouchier C, el al. Dihydrofolate reductase I164L mutation in Pkismodnim fuliiparum, Madagascar Emerg Infect Dis 2008; 14 : 1166-7.
31. Lynch C, Pearce R. Pota H, Cox J, Abeku TA. Rwakimari J, el al. Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda. J Infect Dis 2(K)8 ; 197 : 1598-6(M.
32. Maïga O, Djimdé AA. Hubert V. Renard E, Aubouy A. Kironde F. el at. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J Infect Dis 2007 ; 196 : 165-72.
33. McCollum AM, Poe AC, Hamel M, Huber C, Zhou Z, Shi YR el al. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis 2006 ; 194 : 189-97.
34. Khim N, Bouchier C, Ekala MT, Incardona S, Lim P, Legrand E. et ed. Countrywide survey shows very high prevalence of Plasmodium falciparum inultilocus resistance genotypes in Cambodia. Antimicrob Agents Chemother 2005 ; 49 : 3147-52.
35. Lozovsky ER. Chookajorn T. Brown KM, Imwong M, Shaw PJ. Kamchonwongpaisan S, el al. Stepwise acquisition of pyrimethamine n-sisriiuf in the malaria parasite. Proc Nad Acad Sci USA 2009; 106 : 12025-30
36. Dondorp AM, Nosten P, Yi P, Das D, Phyo AP, Taming J, el at. Artemisinin resistance in Plasmoiliiim falciparum malaria. N EngtJ Med 2009; 361 : 455-67.
37. Noedl H, Si- Y Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, el al. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin infect Dis 2010; 51 : e82-9.
38. Silai R, Moussa M, Abdalli Mari M, Astafieva-Djaza M, Hafidhou M, Ouinadi A, el al. Surveillance de la chimiosensibilité dû à Plasmodium falciparum et changement de politique dans l'Union des Comores, Bull Soc Pathol Exoct 2007: 100 ; 6-9.
39. Parola P Pradines B, Simon F, Cariotti MP, Minodier P, Ranjeva MP, et al. Antimalarial drug susceptibility and point mutations assiKialed with drug resistance in 248 Plasmodium falciparum isolates imponed from Comoros to Marseille, France in 2004 2006. Am J Trop Med Hyg 2007 ; 77 : 431-7.
40. Rebaudet S, Bogrcau H, Silaï R, Lepere JF. Bertaux L. Pradines B el al. Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago. Emerg Infect Dis 2010 ; 16 : 1686-94.
41. Ménard D, Randrianarivo-Solofoniaina AE, Ahmed BS, Jahevitra M, Andriantsoanirina V. Rasolofomanana JR, et al. Drug-resistant malaria parasites introduced into Madagascar from Comoros Islands. Emerg Infect Dis 2007; 13 : 1759-62.
42. Bhattarai A, Ali AS, Kachur SP, Mårtensson A, Abbas AK, Khalib R, el al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 2007 ; 4 : e309.
43. Mårtensson A, Strömberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, et al. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefan-trine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis: 2005 ; 41 : 1079-86.